CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomised, Controlled, Double-blind, Double-dummy, Clinical Trial Comparing Sacubitril-Valsartan Versus Valsartan in Asymptomatic, Stage A/B HFpEF Patients With Elevated Natriuretic Peptide and Abnormal LAVI. (Previously NCT02682719)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04687111
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:10.777290+00:00
Published At: 2021-05-11T00:00:00+00:00
Record Updated At: 2021-05-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Atrial Remodeling", "Myocardial Dysfunction", "Left Ventricular Remodeling", "Left Ventricular Diastolic Dysfunction", "Hypertension", "Cardiovascular Morbidity", "Fibrosis Myocardial", "Inflammatory Myopathy", "Atrial Arrhythmia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-05-11"
protocolSection.identificationModule.nctId: "NCT04687111"
protocolSection.identificationModule.officialTitle: "A Randomised, Controlled, Double-blind, Double-dummy, Clinical Trial Comparing Sacubitril-Valsartan Versus Valsartan in Asymptomatic, Stage A/B HFpEF Patients With Elevated Natriuretic Peptide and Abnormal LAVI. (Previously NCT02682719)"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.